Hydrophobic Interaction Chromatography: A Platform for Characterizing Antibody-Drug Conjugates

News
Article

Sponsored Content

Characterizing the ratio of tumor-killing payload to cancer-binding antibody (DAR) is a critical quality attribute that helps determine the potential potency of a given antibody-drug conjugate (ADC) candidate. The TSKgel® HIC-ADC Butyl column, developed by Tosoh Bioscience, enables improved HIC-based separations for quantifying the DAR of ADCs.

Related Content